Almirall Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALMIRALL, and what generic alternatives to ALMIRALL drugs are available?
ALMIRALL has twelve approved drugs.
There are twenty US patents protecting ALMIRALL drugs.
There are two hundred and eleven patent family members on ALMIRALL drugs in thirty-one countries and thirty-one supplementary protection certificates in fourteen countries.
Drugs and US Patents for Almirall
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Almirall | CORDRAN | flurandrenolide | LOTION;TOPICAL | 013790-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Almirall | SEYSARA | sarecycline hydrochloride | TABLET;ORAL | 209521-002 | Oct 1, 2018 | RX | Yes | No | 9,481,639 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Almirall | CORDRAN | flurandrenolide | TAPE;TOPICAL | 016455-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Almirall | KLISYRI | tirbanibulin | OINTMENT;TOPICAL | 213189-001 | Dec 14, 2020 | RX | Yes | Yes | 7,300,931 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Almirall | ACZONE | dapsone | GEL;TOPICAL | 207154-001 | Feb 24, 2016 | AB | RX | Yes | Yes | 9,517,219 | ⤷ Try a Trial | ⤷ Try a Trial | |||
Almirall | KLISYRI | tirbanibulin | OINTMENT;TOPICAL | 213189-001 | Dec 14, 2020 | RX | Yes | Yes | 11,497,750 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Almirall | KLISYRI | tirbanibulin | OINTMENT;TOPICAL | 213189-001 | Dec 14, 2020 | RX | Yes | Yes | 10,323,001 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Almirall
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Almirall | ACZONE | dapsone | GEL;TOPICAL | 207154-001 | Feb 24, 2016 | 6,060,085 | ⤷ Try a Trial |
Almirall | AZELEX | azelaic acid | CREAM;TOPICAL | 020428-001 | Sep 13, 1995 | 4,386,104 | ⤷ Try a Trial |
Almirall | SOLAGE | mequinol; tretinoin | SOLUTION;TOPICAL | 020922-001 | Dec 10, 1999 | 5,194,247 | ⤷ Try a Trial |
Almirall | SOLAGE | mequinol; tretinoin | SOLUTION;TOPICAL | 020922-001 | Dec 10, 1999 | 6,353,029 | ⤷ Try a Trial |
Almirall | VERDESO | desonide | AEROSOL, FOAM;TOPICAL | 021978-001 | Sep 19, 2006 | 6,730,288 | ⤷ Try a Trial |
Almirall | XOLEGEL | ketoconazole | GEL;TOPICAL | 021946-001 | Jul 28, 2006 | 8,735,393 | ⤷ Try a Trial |
Almirall | ACZONE | dapsone | GEL;TOPICAL | 207154-001 | Feb 24, 2016 | 5,863,560 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ALMIRALL drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Gel | 7.5% | ➤ Subscribe | 2017-02-13 |
International Patents for Almirall Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
China | 101687798 | ⤷ Try a Trial |
Japan | 6022657 | ⤷ Try a Trial |
South Korea | 101243526 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2006071960 | ⤷ Try a Trial |
Japan | 2007504231 | ⤷ Try a Trial |
Poland | 2707003 | ⤷ Try a Trial |
European Patent Office | 3812372 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Almirall Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1304992 | 2013C/060 | Belgium | ⤷ Try a Trial | PRODUCT NAME: CLINDAMYCINE (ALS CLINDAMYCINE FOSFAAT) EN TRETINOINE; AUTHORISATION NUMBER AND DATE: BE437507 20130506 |
1836169 | 2021C/001 | Belgium | ⤷ Try a Trial | DETAILS ASSIGNMENT: CHANGE OF OWNER(S), ASSIGNMENT |
1028961 | 07C0057 | France | ⤷ Try a Trial | PRODUCT NAME: RETAPAMULIN; REGISTRATION NO/DATE IN FRANCE: EU/1/07/390/001 DU 20070524; REGISTRATION NO/DATE AT EEC: EU/1/07/390/001 DU 20070524 |
1836169 | 301145 | Netherlands | ⤷ Try a Trial | DETAILS ASSIGNMENT: CHANGE OF OWNER(S), ASSIGNMENT |
1836169 | 49/2021 | Austria | ⤷ Try a Trial | PRODUCT NAME: TIRBANIBULIN ODER EIN SALZ, SOLVAT ODER HYDRAT DAVON; REGISTRATION NO/DATE: EU/1/21/1558 (MITTEILUNG) 20210719 |
1028961 | C01028961/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: RETAPAMULIN; REGISTRATION NUMBER/DATE: SWISSMEDIC 58641 04.08.2009 |
2435024 | 2190014-7 | Sweden | ⤷ Try a Trial | PRODUCT NAME: A COMBINATION OF FORMOTEROL INCLUDING ANY PHARMACEUUTICALLY ACCEPTABLE SALTS, ESTERS, OR SOLVATES THEREOF, GLYCOPYRROLATE INCLUDING ANY PHARMACEUTICALLY ACCEPTABLE SALTS, ESTERS, OR SOLVATES THEREOF, AND BUDESONIDE INCLUDING ANY PHARMACEUTICALLY ACCEPTABLE SALT, ESTERS ORSOLVATES THEREOF; REG. NO/DATE: EU/1/20/1498 20201210 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.